High refractive index, high Abbe compositions
US-12071497-B2 · Aug 27, 2024 · US
US11213606B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11213606-B2 |
| Application number | US-202016904867-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2020 |
| Priority date | Dec 4, 2013 |
| Publication date | Jan 4, 2022 |
| Grant date | Jan 4, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Soft hydrophobic acrylic materials with improved resistance to fluid diffusion and suitable mechanical properties that allow deformation upon application of force are disclosed. The acrylic materials are particularly suitable for use in fluid-based accommodating intraocular lenses and comprises combination of a perfluoro-substituted alkyl (meth)acrylate and an alkyl (meth)acrylate, and a cross-linking agent.
Opening claim text (preview).
We claim: 1. An accommodating intraocular lens, comprising a soft hydrophobic acrylic material which has a storage modulus of from about 0.5 MPa to about 3.0 MPa as measured by dynamic mechanical analysis under compression mode at about 35° C. and a silicone uptake of less than about 2.0% by weight after accelerated aging in a silicone fluid for 32 days at 70° C., wherein the acrylic material is obtained from a polymerizable composition comprising: a) from about 65% to about 80% by weight of at least one perfluoro-substitued-C 2 -C 12 alkyl (meth)acrylate; b) from about 20% to about 35% by weight of at least one C 2 -C 12 alkyl (meth)acrylate; and c) at least one cross-linking agent, provided that the polymerizable composition is substantially free of any aryl acrylic monomer. 2. The accommodating intraocular lens of claim 1 , wherein the polymerizable composition comprises less than about 2% by weight of any aryl acrylic monomer. 3. The accommodating intraocular lens of claim 2 , wherein the acrylic material is characterized by having a storage modulus of from about 0.75 MPa to about 2.5 MPa measured by dynamic mechanical analysis under compression mode at about 35° C. and a silicone uptake of less than about 1.5% by weight after accelerated aging in a silicone fluid for 32 days at 70° C. 4. The accommodating intraocular lens of claim 2 , wherein the acrylic material is characterized by having a storage modulus of from about 1.0 MPa to about 2.0 MPa measured by dynamic mechanical analysis under compression mode at about 35° C. and a silicone uptake of less than about 1.0% by weight or less after accelerated aging in a silicone fluid for 32 days at 70° C. 5. The accommodating intraocular lens of claim 3 , wherein the polymerizable composition comprises less than about 1% by weight of any aryl acrylic monomer. 6. The accommodating intraocular lens of claim 5 , wherein said at least one perfluoro-substitued-C 2 -C 12 alkyl (meth)acrylate is selected from the group consisting of 2,2,2-trifluoroethyl methacrylate, 2,2,2-trifluoroethyl acrylate, tetrafluoropropyl methacrylate, tetrafluoropropyl acrylate, hexafluoro-iso-propyl methacrylate, hexafluoro-iso-propyl acrylate, hexafluorobutyl methacrylate, hexafluorobutyl acrylate, heptafluorobutyl methacrylate, heptafluorobutyl acrylate, octafluoropentyl methacrylate, octafluoropentyl acrylate, dodecafluoropheptyl methacrylate, heptadecafluorodecyl acrylate, heptadecafluorodecyl methacrylate, pentafluorophenyl acrylate, pentafluorophenyl methacrylate, and combinations thereof. 7. The accommodating intraocular lens of claim 6 , wherein said at least one C 2 -C 12 alkyl (meth)acrylate is selected from the group consisting of ethyl acrylate, ethyl methacrylate, n-propyl acrylate, n-propyl methacrylate, n-butyl acrylate, n-butyl methacrylate, n-pentyl acrylate, n-pentyl methacrylate, n-hexyl acrylate, n-hexyl methacrylate, n-heptyl acrylate, n-heptyl methacryate, n-octyl acrylate, n-octyl methacrylate, n-nonyl acrylate, n-nonyl methacrylate, n-decyl acrylate, n-decyl methacrylate, n-undecyl acrylate, n-undecyl methacrylate, lauryl acrylate, lauryl methacrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, 2,2-dimethylpropyl acrylate, 2,2-dimethylpropyl methacrylate, trimethylcyclohexyl acrylate, trimethylcyclohexyl methacrylate, isobutyl acrylate, isobutyl methacrylate, isopentyl acrylate, isopentyl methacrylate, and mixtures thereof. 8. The accommodating intraocular lens of claim 7 , wherein said at least one cross-linking agent is selected from the group consisting of: ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; where p=1-50; and where t=3-20; their corresponding acrylates; and combinations thereof. 9. The accommodating intraocular lens of claim 8 , wherein the amount of said at least one cross-linking agent in the polymerizable composition is 1% to 5% if the molecular weight of the crosslinking agent is less than 500 Daltons, or is 5% to 17% if the molecular weight of the crosslinking agent is greater than 500 Daltons. 10. The accommodating intraocular lens of claim 9 , wherein the polymerizable composition further comprises one or more polymerizable components selected from the group consisting of a polymerizable UV-absorber, a polymerizable colored dye, and combinations thereof. 11. The accommodating intraocular lens of claim 3 , wherein polymerizable composition comprises heptadecafluorodecyl methacrylate, butyl acrylate, and ethylene glycol dimethacrylate. 12. The accommodating intraocular lens of claim 4 , wherein the polymerizable composition comprises about 0.5% by weight or less of any aryl acrylic monomer. 13. The accommodating intraocular lens of claim 12 , wherein said at least one perfluoro-substitued-C 2 -C 12 alkyl (meth)acrylate is selected from the group consisting of 2,2,2-trifluoroethyl methacrylate, 2,2,2-trifluoroethyl acrylate, tetrafluoropropyl methacrylate, tetrafluoropropyl acrylate, hexafluoro-iso-propyl methacrylate, hexafluoro-iso-propyl acrylate, hexafluorobutyl methacrylate, hexafluorobutyl acrylate, heptafluorobutyl methacrylate, heptafluorobutyl acrylate, octafluoropentyl methacrylate, octafluoropentyl acrylate, dodecafluoropheptyl methacrylate, heptadecafluorodecyl acrylate, heptadecafluorodecyl methacrylate, pentafluorophenyl acrylate, pentafluorophenyl methacrylate, and combinations thereof. 14. The accommodating intraocular lens of claim 13 , wherein said at least one C 2 -C 12 alkyl (meth)acrylate is selected from the group consisting of ethyl acrylate, ethyl methacrylate, n-propyl acrylate, n-propyl methacrylate, n-butyl acrylate, n-butyl methacrylate, n-pentyl acrylate, n-pentyl methacrylate, n-hexyl acrylate, n-hexyl methacrylate, n-heptyl acrylate, n-heptyl methacryate, n-octyl acrylate, n-octyl methacrylate, n-nonyl acrylate, n-nonyl methacrylate, n-decyl acrylate, n-decyl methacrylate, n-undecyl acrylate, n-undecyl methacrylate, lauryl acrylate, lauryl methacrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, 2,2-dimethylpropyl acrylate, 2,2-dimethylpropyl methacrylate, trimethylcyclohexyl acrylate, trimethylcyclohexyl methacrylate, isobutyl acrylate, isobutyl methacrylate, isopentyl acrylate, isopentyl methacrylate, and mixtures thereof. 15. The accommodating intraocular lens of claim 14 , wherein said at least one cross-linking agent is selected from the group consisting of: ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, allyl methacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol dimethacrylate; 1,6-hexanediol dimethacrylate; 1,4-butanediol dimethacrylate; where p=1-50; and where t=3-20; their corresponding acrylates; and combinations thereof. 16. The accommodating intraocular lens of claim 15 , wherein the amount of said at least one cross-linking agent in the polymerizable composition is 1% to 5% if the molecular weight of the crosslinking agent is less
having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside · CPC title
Esters · CPC title
of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate · CPC title
containing perhaloalkyl radicals · CPC title
of polyhydric alcohols or polyhydric phenols · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.